Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitors.
The ability to restrict low molecular weight compounds to the gastrointestinal (GI) tract may enable an enhanced therapeutic index for molecular targets known to be associated with systemic toxicity. Using a triazolopyrazine CSF1R inhibitor scaffold, a broad range of prodrugs were synthesized and ev...
Main Authors: | Dawn M George, Raymond J Huntley, Kevin Cusack, David B Duignan, Michael Hoemann, Jacqueline Loud, Regina Mario, Terry Melim, Kelly Mullen, Gagandeep Somal, Lu Wang, Jeremy J Edmunds |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6128612?pdf=render |
Similar Items
-
Clinical Development of Colony-Stimulating Factor 1 Receptor (CSF1R) Inhibitors
by: Chia-Chi Lin
Published: (2021-05-01) -
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
by: Michael A. Cannarile, et al.
Published: (2017-07-01) -
Chemokine CXCL13 in serum, CSF and blood–CSF barrier function: evidence of compartment restriction
by: Georg Pilz, et al.
Published: (2020-02-01) -
The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines.
by: Andrea Morandi, et al.
Published: (2011-01-01) -
ISOLATION OF YACS FOR CSF-1R AND CSF-1 AND GENE LOCALIZATION USING FISH
by: Boultwood, J, et al.
Published: (1992)